APA

Gnanapragasam V. J., Barrett T., Thankapannair V., Thurtle D., Rubio-Briones J., Domínguez-Escrig J., Bratt O., Statin P., Muir K. & Lophatananon A. (20200601). Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer. : BJU international.

Chicago

Gnanapragasam Vincent J, Barrett Tristan, Thankapannair Vineetha, Thurtle David, Rubio-Briones Jose, Domínguez-Escrig Jose, Bratt Ola, Statin Par, Muir Kenneth and Lophatananon Artitaya. 20200601. Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer. : BJU international.

Harvard

Gnanapragasam V. J., Barrett T., Thankapannair V., Thurtle D., Rubio-Briones J., Domínguez-Escrig J., Bratt O., Statin P., Muir K. and Lophatananon A. (20200601). Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer. : BJU international.

MLA

Gnanapragasam Vincent J, Barrett Tristan, Thankapannair Vineetha, Thurtle David, Rubio-Briones Jose, Domínguez-Escrig Jose, Bratt Ola, Statin Par, Muir Kenneth and Lophatananon Artitaya. Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer. : BJU international. 20200601.